Cancer Care Inc is categorized under Social Service and Welfare Organizations in Metuchen, NJ .
Cancer Care Inc was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Social Service and Welfare Organizations business, which does work in the B2C market, and is classified as a Social Service and Welfare Organizations, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Karen Calimore at the company’s single location by writing to 652 Middlesex Avenue, Metuchen, New Jersey NJ 08840 or by phoning (732) 549-5959. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cancer Care Inc |
| Contact Person: | Karen Calimore |
| Address: | 652 Middlesex Avenue, Metuchen, New Jersey 08840 |
| Phone Number: | (732) 549-5959 |
| Website Address: | cancercare.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Social Service and Welfare Organizations |
| SIC Code: | 8322 |
| NAICS Code: | 6211110 |
| Share This Business: |
Cancer Care Inc was started in 0 to provide professional Social Service and Welfare Organizations under the SIC code 8322 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Karen Calimore for inquiries that concern Cancer Care Inc by calling the company number (732) 549-5959, as your correspondence is most welcome. Additionally, the physical location of the single location of Cancer Care Inc can be found at the coordinates 40.54067,-74.36697 as well as the street address 652 Middlesex Avenue in Metuchen, New Jersey 08840.
For its online presence, you may visit Cancer Care Inc’s website at cancercare.org and engage with its social media outlets through on Twitter and on Facebook.